Skip to main content

Science Applications International Corp

For the period ended Aug 1, 2025. Filed Sep 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Aug 1, 2025 · Filed Sep 4, 2025

SAIC$146.30-0.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended August 1, 2025

or

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission File Number001-35832
Science Applications International Corporation
(Exact name of registrant as specified in its charter)
Delaware46-1932921
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
12010 Sunset Hills Road,Reston,Virginia20190
(Address of principal executive offices)(Zip Code)
(703)676-4300
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $.0001 per shareSAICThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer☒Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐ No ☒

The number of shares issued and outstanding of the registrant’s common stock as of August 22, 2025 was as follows:

46,022,001 shares of common stock ($.0001 par value per share)

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

FORM 10-Q

TABLE OF CONTENTS

Page
Part I · Financial Information
Item 1Financial Statements1
Condensed Consolidated Statements of Income1
Condensed Consolidated Statements of Comprehensive Income2
Condensed Consolidated Balance Sheets3
Condensed Consolidated Statements of Equity4
Condensed Consolidated Statements of Cash Flows5
Notes to Condensed Consolidated Financial Statements6
Note 1—Business Overview and Summary of Significant Accounting Policies6
Note 2—Earnings Per Share, Share Repurchases and Dividends8
Note 3—Revenues10
Note 4—Goodwill and Intangible Assets12
Note 5—Income Taxes13
Note 6—Debt Obligations14
Note 7—Derivative Instruments Designated as Cash Flow Hedges15
Note 8—Changes in Accumulated Other Comprehensive Income (Loss) by Component16
Note 9—Sales of Receivables17
Note 10—Business Segments Information17
Note 11—Legal Proceedings and Other Commitments and Contingencies19
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations21
Item 3Quantitative and Qualitative Disclosures About Market Risk31
Item 4Controls and Procedures31
Part IIOther Information32
Item 1Legal Proceedings32
Item 1ARisk Factors32
Item 2Unregistered Sales of Equity Securities and Use of Proceeds32
Item 3Defaults Upon Senior Securities33
Item 4Mine Safety Disclosures33
Item 5Other Information33
Item 6Exhibits34
Signatures35

-i-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.